共 50 条
Integrating Exposure and Response Prevention With a Mobile App to Treat Obsessive-Compulsive Disorder: Feasibility, Acceptability, and Preliminary Effects
被引:11
|作者:
Gershkovich, Marina
[1
,2
]
Middleton, Rachel
[1
,2
]
Hezel, Dianne M.
[1
,2
]
Grimaldi, Stephanie
[3
]
Renna, Megan
[4
]
Basaraba, Cale
[1
]
Patel, Sapana
[1
,2
]
Simpson, H. Blair
[1
,2
]
机构:
[1] New York State Psychiat Inst & Hosp, 1051 Riverside Dr, New York, NY 10025 USA
[2] Columbia Univ, Med Ctr, New York, NY 10027 USA
[3] Hofstra Univ, Hempstead, NY 11550 USA
[4] Ohio State Univ, Coll Med, Columbus, OH 43210 USA
关键词:
cognitive-behavioral therapy;
treatment;
OCD;
mobile app;
technology;
COGNITIVE-BEHAVIORAL THERAPY;
CONTROLLED-TRIAL;
SELF-HELP;
METAANALYSIS;
SCALE;
INTERVENTIONS;
REMISSION;
ANXIETY;
D O I:
10.1016/j.beth.2020.05.001
中图分类号:
B849 [应用心理学];
学科分类号:
040203 ;
摘要:
Many individuals with obsessive-compulsive disorder (OCD) do not receive evidence-based care (specifically exposure and ritual prevention; EX/RP) due to barriers such as a lack of EX/RP-trained clinicians, geographic obstacles, and the cost and time associated with the treatment. Offering an integrated treatment model consisting of brief in-person therapy coupled with a mobile application (app) might be one way to increase access to and reduce the time burden (to clinicians and patients) of EX/RP. This pilot trial evaluated the feasibility, acceptability, and clinical effects of such a treatment program for adults with OCD. Thirty-three participants enrolled in the 8-week open trial. The integrated treatment program consisted of 3 to 5 in-person sessions followed by weekly phone calls supported by a mobile app (nOCD). Participants were evaluated by trained raters and completed self-report measures at baseline, midtreatment, posttreatment and 2-month follow-up; the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) was the primary outcome. This integrated treatment program was feasible and acceptable to participants. Of the 33 study entrants, 14 (42%) responded to treatment (Y-BOCS decrease >= 35% with CGI- of 1 or 2), and 8 (24%) achieved minimal symptoms (i.e., Y-BOCS <= 12). At 2-month follow-up (n=20), 7/20 (35%) met criteria for treatment response, and 3/20 (15.0%) met criteria for treatment remission. Although preliminary, this model warrants further study as an efficacious and resource-efficient way to deliver EX/RP for some patients with OCD.
引用
收藏
页码:394 / 405
页数:12
相关论文